Article info
PDFExtended essay
Value assessment frameworks: who is valuing the care in healthcare?
- Correspondence to Professor Jonathan Anthony Michaels, Health Economics and Decision Science, University of Sheffield School of Health and Related Research, Sheffield S1 4DA, UK; j.michaels{at}sheffield.ac.uk
Citation
Value assessment frameworks: who is valuing the care in healthcare?
Publication history
- Received May 25, 2020
- Revised October 27, 2020
- Accepted February 8, 2021
- First published March 9, 2021.
Online issue publication
May 23, 2022
Article Versions
- Previous version (9 March 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- National Institute for Clinical Excellence and its value judgments
- NICE is dead; long live NICE
- Not a NICE fallacy: a reply to Dr Quigley
- National Institute for Health and Clinical Excellence appraisal and ageism
- A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors
- The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process
- Ethics and opportunity costs: have NICE grasped the ethics of priority setting?
- NICE discrimination
- Quality-adjusted life years
- Cost-effectiveness of cardiovascular imaging for stable coronary heart disease